Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

June 9, 2015July 2, 2015

Genetic Risk Score Predicts Appropriate Age to Begin Colorectal Cancer Screening

Models to predict the risk of patients developing colorectal cancer are powerful tools that can be used to help augment screening and prevention strategies. A group of researchers from Fred ... Read more

May 11, 2015May 11, 2015

Anti-Cancer Stem Cell OH14 Licensed to Tiziana from Cardiff University

A new compound developed in a laboratory at Cardiff University holds great potential for fighting colon cancer. The compound, OH14, in now under license at Tiziana Life Sciences, which is ... Read more

April 27, 2015April 27, 2015

Silibinin from Milk Thistle Extract Halts Colon Cancer Stem Cells

A nontoxic chemical extracted from milk thistle, a purple flower that grows around the world, may help stop the growth of colon cancer stem cells. Silibinin, the purified chemical, was shown ... Read more

April 17, 2015April 18, 2015

“Nontoxic” Salmonella Kills Colon Cancer Cells

Colon cancer cells are no match for Salmonella enterica. However, there is risk for using Salmonella as part of cancer therapy, as the microbe wreaks havoc on the human body. It ... Read more

April 14, 2015April 14, 2015

mTOR Inhibitors Revealed To Be Strong Anti-Colon Cancer Agents

Colon cancer is often associated with the mammalian target of rapamycin (mTOR), a serine/threonine kinase activated in a range of cellular activities such as growth, proliferation, and migration. A new ... Read more

March 31, 2015March 31, 2015

E. coli Linked to Endoscopes in Colon Cancer Screenings

Individuals looking to decrease their risk for colon cancer by opting for a preventative colonoscopy may be at a risk for exposure to Escherichia coli. A hospital in Washington state ... Read more

February 20, 2015February 20, 2015

Intracellular Calcium Affects Colon Cancer Cell Motility

A calcium supplement a day may not make metastatic colon cancer go away. In fact, as reported in a new article from Gachon University in the Republic of Korea, dietary ... Read more

January 28, 2015January 28, 2015

New Strategy for Ras-Associated Colon Cancer Treatment

Colon cancer is one of the three highly fatal cancers caused by a protein called Ras. Professor Dimitrios Stamou, head of a multidisciplinary team in bio-nanotechnology and nanomedicine at University ... Read more

January 7, 2015January 7, 2015

Colon Cancer Affected By Number Of Stem Cell Divisions

A statistical-based computer model created by two scientists at the Johns Hopkins Kimmel Cancer Center places colon cancer in the category of cancers due to bad luck, environmental factors, and ... Read more

November 25, 2014November 25, 2014

Four Genes Used to Predict Rectal Cancer Patient Response to CRT

Identifying a certain subset of genes in individuals with locally advanced rectal cancer (LARC) could be useful in determining the most cost- and time-effective treatment options for patients, according to ... Read more

October 23, 2014October 23, 2014

Genetic Tests in Population Leave Colorectal Cancer Screening Rates Unchanged

An “excellent” study–defined as such by meeting the randomized controlled trial requirement of Level I Evidence in medicine–from the Fox Chase Cancer Center and Jefferson Medical College in Pennsylvania and ... Read more

October 15, 2014October 15, 2014

EpHA2 Protein Linked to Poor Colorectal Cancer Prognosis

Clinicians may be able to use another prognostic marker for colon cancer in order to make decisions for the best treatment option for their patients. A new study from Queen’s ... Read more

October 7, 2014October 7, 2014

Clinically Relevant JAK Inhibitors Battle Colon Cancer in Pre-Clinical Studies

An effective new therapy used against bowel cancer tumors may be quickly propelled from laboratory testing to clinical trials for subsequent approval. The therapy, already in use to treat psoriasis, arthritis, ... Read more

October 1, 2014October 1, 2014

Benefits of Colorectal Cancer Screening Evaluated in French Studies

As suggested by a study presented at the ESMO 2014 Congress, biennial colorectal screening initiatives may increase the rate of high risk pre-cancerous adenomas diagnosis by nearly 90%. In Côte-d’Or, ... Read more

September 5, 2014September 5, 2014

Prediction Model Estimates Time of Colorectal Cancer Patient Survival

“How long do I have, doctor?” is a question on the minds of many patients diagnosed with metastatic colorectal cancer. In light of a new study published in Annals of Oncology entitled ... Read more

August 28, 2014August 30, 2014

Colon Cancer Risk Mitigated by Sigmoidoscopy in Ten-Year Study

Sigmoidoscopy, a medical procedure analogous to a less invasive colonoscopy, can cut the risk for developing or dying from colon cancer. The finding, published in the Journal of the American Medical ... Read more